Oral-Systemic Link: Page 133

Odontoblast cells protect teeth from decay

By DrBicuspid.com staff writers

Odontoblast cells, part of the human body's natural immune system, also fight to protect teeth from decay, according to new research to be published in BMC Immunology (in press).

January 24, 2011

Amgen to pay $1B for firm developing head/neck cancer drug

By DrBicuspid.com staff writers

Biotechnology giant Amgen has agreed to acquire BioVex Group, a privately held biotechnology company that is developing OncoVex, a novel oncolytic vaccine to treat head and neck cancer and melanoma.

January 23, 2011

Confounding lesions make oral cancer harder to detect

By Kathy Kincade

SAN FRANCISCO - While commercial autofluorescence devices can help clinicians identify premalignant lesions in the oral cavity, the prevalence of confounding lesions increases the rate of false positives, according to researchers at this week's SPIE BiOS meeting.

January 23, 2011

HeartFriendly Dentist program debuts in Canada

By DrBicuspid.com staff writers

bioAnalytics has introduced its HeartFriendly Dentist program to dental professionals in Canada and is partnering with Biosign Technologies to offer participants a unique health-monitoring device for their patients.

January 20, 2011

Cancer patients suffer unique oral complications

By Donna Domino

With more than 1.4 million new cases of cancer diagnosed each year, dental practitioners are more likely than ever to see these patients in their practices. A literature review in Oral Diseases offers advice on how to manage the oral side effects of chemotherapy and radiation treatments.

January 20, 2011

Radiation therapy helps HIV-positive head/neck cancer patients

By DrBicuspid.com staff writers

HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience toxicity rates similar to HIV-negative patients, according to a study in the International Journal of Radiation Oncology, Biology, Physics.

January 18, 2011